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Prosthetic graft infection remains one of the
most dreaded complications of reconstructive vascu-
lar surgery, especially when the aorta is involved.
Despite optimal surgical technique and appropriate
systemic antibiotic prophylaxis, the incidence of
graft infection persists to range between 1.0% and
6.0%.1-3 Although continuous improvement in
results has been achieved over the past decade, pros-
thetic graft infection is still associated with high
mortality and amputation rates.4-6 Dissatisfaction
with extraanatomic techniques has led to the devel-
opment of approaches of in situ replacement by
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Purpose: The purposes of this study were to prove the efficacy of cryopreserved aortic
allografts to treat an established vascular graft infection by in situ replacement in an ani-
mal model and to evaluate the role of the antibiotics normally used to decontaminate the
allografts.
Methods: Twenty-three dogs underwent infrarenal aortic replacement with a gelatin-
sealed knitted polyester graft contaminated in vitro by Staphylococcus epidermidis RP-62.
One week later, the 18 surviving animals underwent reoperation for graft removal and
were randomized into three groups for in situ replacement: group I (control, n = 6)
received a new gelatin-sealed graft; group II (n = 6) received a non–antibiotic-treated
cryopreserved allograft; and group III (n = 6) received an antibiotic-treated cryopre-
served allograft. Control grafts and allografts were removed 4 weeks after the initial
intervention for quantitative bacteriologic analysis and histologic analysis. Bacteriolog-
ic results were expressed as colony-forming units per square centimeter of graft materi-
al. Qualitative bacteriologic analysis was also obtained from perigraft fluid and tissue.
Results: All of the initially implanted grafts and all of the control grafts (group I) were
infected at the time of removal. In group II, three out of six allografts were not totally
incorporated, whereas in group III incorporation was always complete, with a signifi-
cantly decreased inflammatory reaction. All of the antibiotic-treated allografts were ster-
ile, whereas three untreated allografts grew bacteria.
Conclusions: In this model, cryopreserved aortic allografts were more resistant to rein-
fection than synthetic grafts after in situ replacement of an infected prosthetic graft.
However, the antibiotic loading of the cryopreserved aortic allograft appears to be
essential to obtain optimal therapeutic effects. (J Vasc Surg 1998;27:689-98.)
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prosthetic,7-9 autogenous,10-12 or allograft13 mater-
ial to avoid complications related to aortic stump
disease and subsequent infection and occlusion of
extraanatomic bypass grafts.14
In situ replacement with so-called “fresh” aortic
allografts preserved at 4° C has been used by Kieffer
and associates13 in 43 patients to treat aortic graft
infections with very encouraging early and midterm
results. Experimental and clinical data suggest that
fresh arterial allografts are more resistant to bacteri-
al contamination than prosthetic grafts.13,15,16
However, conservation at 4° C is a less-than-
optimal method. The limited duration of storage
precludes effective tissue banking, matching of
donor/recipient blood or tissue compatibility, and a
sufficient prevention of viral transmission before
transplantation. Cryopreservation might be the opti-
mal technique to solve these problems.
To date, the clinical experience with cryopre-
served aortic allografts to treat prosthetic graft infec-
tions or mycotic aneurysms of the aorta is still limit-
ed to small numbers of patients.17-19 Nevertheless,
the excellent results obtained in cardiac surgery with
cryopreserved allografts in managing infections of
the aortic valve and the ascending aorta20,21 in larg-
er numbers of patients suggest that cryopreserved
allografts are also a suitable replacement graft mate-
rial for prosthetic graft infection in the abdominal
aortic region.
The purposes of this study were to prove the effi-
cacy of cryopreserved aortic allografts to treat an
established vascular graft infection by in situ replace-
ment in an animal model and to evaluate the role of
the antibiotics normally used for decontamination of
the allograft during the cryopreservation process.
MATERIAL AND METHODS
Graft material. Standard, commercially avail-
able gelatin-sealed knitted polyester prostheses (Gel-
soft, Vascutek Limited, Inchinnan, Scotland) were
used in this study. All grafts were 6 mm in diameter.
Aortic allografts. The descending thoracic and
abdominal aortas of four dogs were harvested under
sterile conditions and were cut into 6 cm segments,
which were stored according to the study groups.
Preservation of allografts. Immediately after
excision, 12 aortic allograft segments were stored at 4°
C in a sterile preservation fluid containing polyethyl-
ene glycol (Microval, Braun Medical S.A., Boulogne,
France) and were transported in isothermic boxes to
the tissue bank of Saint-Louis Hospital in Paris. After
a maximal period of 4 hours, the allografts were fur-
ther prepared inside a first-grade laminar flow room.
The allografts were transferred for 48 hours in a con-
servation medium (Plasmagel, Bellon, Neuilly sur
Seine, France) that was or was not, according to the
study group, supplemented with antibiotics (van-
comycin 0.3 mg/ml, lincomycin 0.125 mg/ml) nor-
mally used for the decontamination of vascular grafts
in the tissue bank. To submit the allografts to the cry-
opreservation process, the grafts were placed for 120
minutes in a cryopreservation medium consisting of
Ringer’s solution, polyethylene glycol 20.000 d, 30
g/L, and 12.5% dimethylsulfoxide (B. Braun,
Boulogne, France).22 The grafts were then cryopre-
served at a computer-controlled rate in a freezer that
lowered the temperature 1° C per minute down to a
temperature of –40° C and 5° C per minute down to
–130° C. The increase in temperature during the crys-
tallization process was minimized by a close control of
the rate during this period. The specimens were then
placed in the vapor phase of a liquid nitrogen freezer.
Before implantation the allografts were prepared
in the operating room. The allograft was thawed in
a water bath at 42° C and was then rinsed in succes-
sive baths of saline solution that contained decreas-
ing concentrations of dimethylsulfoxide (8%, 4%,
2%, NaCl 0.9%). No fractures were observed. Before
cryopreservation and before implantation, speci-
mens of all allografts were submitted to bacteriolog-
ic analysis to rule out a contamination during the
preservation process.
Bacterial strain. Staphylococcus epidermidis RP-
62 was used in this study. This clinical isolate provid-
ed by the Department of Genetics and Microbiology
of the Faculty of Medicine of Geneva has been used
in previous experiments.23 This organism demon-
strated slime production when incubated in trypti-
case soy broth with 1% dextrose for 18 hours at 37°
C. The strain was susceptible to vancomycin with a
minimal inhibitory concentration of 2.0 mg/L and
was resistant to lincomycin (minimal inhibitory con-
centration, >1024 mg/L). According to the diffu-
sion disk agar method with the recommendations of
the French Committee of Antibiogram, the strain
was susceptible to tetracycline, chloramphenicol,
pristinamycin, rifampin, vancomycin, teicoplanin,
fusidic acid, pefloxacin, and fosfomycin and was resis-
tant to penicillin G, methicillin (heterologous), gen-
tamicin, tobramycin, kanamycin, erythromycin, lin-
comycin, and trimethoprim, associated or not with
sulfamids.24 When identified with an Api-Staph 
system (Apisystem, La Balme-les Grottes, France),
S. epidermidis RP-62 fermented glucose, fructose,
maltose, lactose, and was positive for nitrate reduc-
tase, Voges-Proskauer, saccharose, arginine test, and
urea reactions.
For inoculum preparation, S. epidermidis RP-62
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was cultivated on sheep blood agar (SBA) plates
(BioMérieux, Marcy l’Etoile, France) in an aerobic
atmosphere at 37° C for 18 hours. Then four fresh-
ly grown colonies were inoculated into 40 ml of
trypticase soy broth with 1% dextrose and were incu-
bated for 18 hours at 37° C. The number of viable
organisms present after an 18-hour incubation was
expressed as the number of colony forming units
(CFU) per milliliter of broth.
In vitro graft colonization. Gelatin-sealed
knitted polyester grafts were colonized in vitro.
They were immersed in an 18-hour incubating
broth of S. epidermidis RP-62 for 15 minutes at
room temperature. After immersion the grafts were
rinsed gently with 20 ml of regular sterile saline
solution to remove nonadherent microorganisms.
Animal model. After intravenous administra-
tion of pentobarbital (30 mg/kg), 23 mongrel dogs
weighing 15 to 20 kg were orally intubated and
mechanically ventilated. Through a median laparot-
omy, they underwent replacement of the infrarenal
aorta with a gelatin-sealed polyester vascular pros-
thesis under sterile surgical conditions. The
infrarenal aorta was transected, and a 5 cm segment
of graft was inserted in an end-to-end fashion with
6-0 Prolene sutures (Ethicon, Neuilly sur Seine,
France). Before implantation the graft was colonized
in vitro as described above. After implantation, the
graft was covered by reapproximating the retroperi-
toneum, and the abdomen was closed in layers with
a standard surgical technique.
One week after the initial graft had been implant-
ed, the surviving animals underwent reoperation.
The aortic graft was exposed through the previous
midline incision with sterile surgical technique. After
proximal and distal control of the aorta adjacent to
the graft, local signs of infection were noted, includ-
ing tissue inflammation, perigraft fluid and cavity for-
mation, absence of graft incorporation, anastomotic
dehiscence, and false aneurysm formation, which was
defined as an anastomotic weakening associated with
an eccentric dilatation of the aortic wall. The graft
was then completely excised, including anastomotic
sites and 5 mm of abdominal aorta proximal and dis-
tal to the graft, and the retroperitoneum was debrid-
ed. Specimens of the anastomotic sites and perigraft
tissues were submitted to histologic studies. The
prosthetic graft, the perigraft tissues, and the peri-
graft fluid were also submitted to bacteriologic analy-
sis with bacterial counts.
The animals were then randomly assigned to one
of three experimental groups: in group I (control, n
= 6) animals received an untreated gelatin-sealed
knitted polyester vascular prosthesis; in group II
(untreated allografts, n = 6) they received a cryopre-
served allograft that was not treated with antibiotics;
and in group III (antibiotic-treated allografts, n = 6)
they received an allograft treated with antibiotics. In
each case the replacement graft, 6 cm in length, was
implanted in situ in an end-to-end fashion with 6-0
polypropylene sutures. The graft was again covered
with the retroperitoneum, and the abdomen was
closed in layers. No adjunct systemic antibiotic ther-
apy was administrated to the animals.
Four weeks after the initial intervention all ani-
mals were anesthetized and killed to recover the
specimen for bacteriologic and histologic analysis.
Venous blood was sampled just before death for
qualitative blood culture. The grafts were evaluated
for graft patency, false aneurysm formation, the
degree of graft incorporation, and the presence of
perigraft fluid or cavity. The prosthetic grafts or the
allografts and the adjacent aorta were totally excised.
Specimens of lung, liver, spleen, and kidney were
also taken for bacteriologic culture. The grafts were
rinsed gently with 20 ml of normal saline solution
and were submitted to bacterial counts. Specimens
of the perigraft tissues were taken separately for his-
tologic and bacteriologic studies. Specimens of the
anastomotic sites were taken for histologic studies.
All animals received humane care in compliance
with the “Principles of Laboratory Animal Care” and
the Guide for the Care and Use of Laboratory Animals
(NIH Publication No. 86-23, revised 1985).
Bacteriologic studies. All removed polyester
grafts and allografts were weighed, and their length
and internal diameter were measured. Then each graft
was cut into two fragments. Weighing each fragment
allowed the determination of its surface. Each frag-
ment was hand-crushed for 2 minutes after addition
of 2 ml normal sterile saline solution. The crushing
effluent was submitted to adequate successive tenfold
dilutions, and 0.1 ml aliquots were cultured onto SBA
plates at 37° C for 48 hours. Colony counts were
expressed as the number of CFU per cm2 of graft
material. Venous blood obtained just before graft
explantation was cultivated in a blood culture bottle
(Hemoline Performance Diphasique, BioMérieux,
Marcy l’Etoile, France) at 37° C for 48 hours.
The perigraft tissues were hand-crushed for 2
minutes after addition of 2 ml normal sterile saline
solution and were cultured onto SBA plates at 37° C
for 48 hours. Organ specimens (lung, spleen, liver,
and kidney) and perigraft fluid were cultivated in
buffered dextrose broth (Sanofi Diagnostic Pasteur,
Marnes-la-Coquette, France) for 48 hours at 37° C.
Subcultures were made for each broth using SBA
plates incubated for 48 hours at 37° C. When Gram-
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positive cocci were isolated, they were identified
with genus-specific Apisystem (Apisystem, La
Balme-les-Grottes, France), and their susceptibility
to antibiotics was determined using the agar disk
antibiotic diffusion method.
Histologic studies. During explantation of the
prosthetic grafts and allografts, specimens were
taken from the perigraft tissues and the proximal and
distal aortic anastomotic sites. After fixation in 10%
buffered formaldehyde solution, the specimens were
embedded in paraffin, sectioned, and stained with
hematoxylin-eosin. Histologic parameters of inflam-
mation assessed in this study were the density of cel-
lular infiltration, the amount of polymorphonuclear
cells, and the absence or presence of suppurative
necrosis. Aortitis was defined as an inflammatory
cellular infiltration of the aortic media with poly-
morphonuclear cells.
Statistical analysis. The results of the macro-
scopic evaluation (false aneurysms, anastomotic dis-
ruption, perigraft inflammation; Table I) and the
results of the microscopic evaluation of perigraft tis-
sues (Table II) and anastomotic sites (Table III)
were summed up and expressed as a mean score in
each experimental group for initial grafts and
replacement grafts, respectively.
The data from the study were analyzed with c 2
analysis and, when appropriate, the one-tailed Fisher’s
exact test for small groups or Mann-Whitney-Wilcox-
on test. Statistical significance was assigned when p
values were less than 0.05.
RESULTS
The median number of viable organisms present
in the inoculum used for the in vitro colonization of
the prosthetic grafts before their implantation in the
in vivo experiments was 8.5 · 108 CFU/ml (range,
106 to 4 · 109) without significant difference
between the experimental groups.
Five animals died before reoperation and in situ
replacement. Three had an anastomotic disruption 5
or 6 days after operation, and two died from sepsis
on postoperative days three and four, respectively.
Eighteen animals were thus included in the study.
Pathologic findings. At the time of retrieval,
all 18 initially implanted grafts and the six prosthet-
ic replacement grafts of the control group (group I)
revealed anatomic signs of infection (Table I). All of
these grafts except one in group II were patent. The
retroperitoneum was involved with acute inflamma-
tion of these 24 prosthetic grafts and adjacent struc-
tures. All of the prosthetic grafts were not incorpo-
rated and surrounded by a cavity that extended to
the anastomoses and contained a suppurative exu-
date. Seventeen grossly infected pseudoaneurysms
were found. In the control group, two animals died
before scheduled, one of sepsis and the other of
anastomotic disruption. All of the animals that were
treated with allograft replacement were healthy at
the time of death. Four weeks after the initial inter-
vention all of the antibiotic-treated allografts (group
III) and three of the six untreated allografts (group
II) were perfectly incorporated without any sign of
inflammation or pseudoaneurysm formation. Three
of the untreated allografts were not completely
incorporated and revealed macroscopic signs of peri-
graft inflammation, but without perigraft fluid.
On microscopic examination, perigraft tissues
of all of the initial grafts showed evidence of an
inflammatory infiltration with lymphocytes and
macrophages (Fig. 1). Polymorphonuclear cells
were present in 72% of the samples, and suppura-
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Table I. Macroscopic evaluation of prosthetic grafts and cryopreserved aortic allografts
Graft False Anastomotic Perigraft Graft Mean 
patency rate aneurysms disruption inflammation incorporation score*
Group I
Initial grafts 6/6 6/6 0/6 6/6 0/6 12/18
Control grafts 6/6 4/6 1/6 6/6 0/6 11/18 (NS)
Group II
Initial grafts 5/6 3/6 0/6 6/6 0/6 9/18
Untreated allografts 5/6 0/6 (NS) 0/6 3/6 (NS) 3/6 (NS) 3/18 (p < 0.04)
Group III
Initial grafts 6/6 4/6 0/6 6/6 0/6 10/18
AB-treated allografts 6/6 0/6 (p < 0.03) 0/6 0/6 (p < 0.01) 6/6 (p < 0.01) 0/18 (p < 0.002)
*Mean score is false aneurysms + anastomotic disruption + perigraft inflammation.
Initial grafts, colonized gelatin-sealed knitted polyester grafts implanted for 7 days; control grafts, in situ replacement with gelatin-sealed
knitted polyester grafts; untreated allografts, cryopreserved aortic allografts prepared without antibiotics; AB-treated allografts, cryopre-
served aortic allografts prepared with antibiotics; NS, not significant.
p values are for allografts versus initial grafts.
tive necrosis was found in 17% of them (Table II).
In the samples of perigraft tissue of the untreat-
ed allografts, inflammatory infiltration was found in
four of six samples, with presence of polymorphonu-
clear cells in three samples. In these three cases the
grafts were macroscopically unincorporated. In the
group that received antibiotic-treated allografts
(group III), perigraft inflammatory infiltration was
found in two of six specimens, with polymorphonu-
clear cells in one of these two specimens. The other
had no signs of inflammation (Fig. 2). After 3 weeks,
the amount of suppurative necrosis did not change
significantly in the experimental groups when com-
pared with the results of the initial grafts (p = NS).
The adventitia of the aortic anastomotic sites of
the initial grafts was infiltrated with inflammatory
cells in 83% of cases (Fig. 3). In this infiltrate, poly-
morphonuclear cells were found in 61% of the spec-
imens (Table III). In groups II and III, 3 weeks after
allograft replacement, the incidence of anastomotic
inflammatory infiltration was 67% (8 of 12 in each
group), and polymorphonuclear cells were present
in 37.5% (3 of 8 in each group) of the explants. The
other explanted allografts had no evidence of inflam-
mation (Fig. 4).
Bacteriologic cultures. The results of bacterio-
logic cultures are shown in Table IV. At the time of
reoperation, all of the initially implanted prosthetic
grafts were infected with S. epidermidis RP-62. There
was no significant difference (p = NS) in the density
of bacteria measured in the initial grafts of the differ-
ent study groups. All of the prosthetic replacement
grafts (group I) were infected at the time of retrieval.
In group II, the study strain was found in one allo-
graft (Table IV). In two other animals of group II,
the allografts were not incorporated and grew other
bacteria. One grew group C b -hemolytic streptococci
(3.5 · 104 CFU/cm2) and the other grew S. chro-
mogenes (3.34 · 105 CFU/cm2). None of the antibi-
otic-treated allografts of group III was infected,
whereas all of the prosthetic replacement grafts
(group I) grew S. epidermidis RP-62 (p < 0.01 when
compared with group III). No concomitant growth
of other bacteria was observed in group III.
The perigraft fluid and tissues taken during reop-
eration and at the time of death in the control group
grew S. epidermidis RP-62 in 50% and 25% of cases,
respectively, whereas bacteriologic cultures of the
perigraft tissues surrounding the allografts always
had negative results. In these experiments, all organ
and blood samples were sterile.
DISCUSSION
This study demonstrates the efficacy of in situ
replacement by cryopreserved aortic allografts to
treat an established S. epidermidis vascular graft
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Fig. 1. Perigraft tissues of a dog 7 days after implantation of an infected gelatin-sealed knit-
ted polyester graft. Hematoxylin-eosin stain at original magnification of · 80 shows inflamma-
tory infiltration in the soft tissues with polymorphonuclear cells.
infection. The model of infrarenal aortic S. epider-
midis polyester graft infection that we used mimics
the clinical situation of late graft infection, resulting
in a perigraft inflammatory process and anastomotic
false aneurysm formation.23,25,26 This model proba-
bly differs from the clinical setting only in regard of
the degree of contamination and the required time
before the infection is established.23,26
The study strain was a clinical isolate of S. epi-
dermidis, which now causes an increasing number of
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Fig. 2. Perigraft tissues of a dog 21 days after implantation of an antibiotic-treated allograft.
Hematoxylin-eosin stain at original magnification of · 80 demonstrates noninflammatory fibro-
tic tissue.
Fig. 3. Perianastomotic tissues of a dog 7 days after implantation of an infected gelatin-sealed
knitted polyester graft. Hematoxylin-eosin stain at original magnification of · 80 demonstrates
suppurative necrosis in perianastomotic fibrosis (*) adjacent to the media (M), which shows
calcification.
vascular prosthetic graft infections.8 These organ-
isms produce an extracellular matrix of glycocalyx
that facilitates bacterial adherence and colonization
of the graft material and protects the bacteria from
host defenses and antibiotic penetration. The
applied technique of in vitro colonization enables a
high reproducibility in the quantitative colonization
of prosthetic grafts23 with a constant vascular graft
infection after 1 week of implantation.
As demonstrated in the animals of group II,
untreated cryopreserved aortic allografts are more
resistant to reinfection than prosthetic grafts. Three
out of six prosthetic graft infections could be suc-
cessfully treated by in situ replacement with a cryop-
reserved aortic allograft within a 3-week period of
time without any local or systemic antibiotic treat-
ment. These allografts were macroscopically perfect-
ly incorporated with negative bacterial cultures and
decreased histologic signs of inflammation when
compared with the initial grafts. This is remarkable
because the replacement allografts were implanted
into a field of acute infection of perigraft tissues and
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Table II. Microscopic evaluation of the perigraft tissues of prosthetic grafts and cryopreserved aortic allo-
grafts
Inflammatory Polymorphonuclear Suppurative Mean
infiltration cells necrosis score*
Group I
Initial grafts 6/6 4/6 2/6 12/18
Control grafts 6/6 5/6 (NS) 2/6 13/18 (NS)
Group II
Initial grafts 6/6 4/6 0/6 10/18
Untreated allografts 4/6 3/6 (NS) 2/6 (NS) 9/18 (NS)
Group III
Initial grafts 6/6 5/6 1/6 12/18
AB-treated allografts 2/6 (p < 0.03) 1/6 (p < 0.05) 1/6 4/18 (p < 0.01)
*Mean score is inflammatory infiltration + polymorphonuclear cells + suppurative necrosis. Initial grafts, colonized gelatin-sealed knit-
ted polyester grafts implanted for 7 days; control grafts, in situ replacement with gelatin-sealed knitted polyester grafts; untreated allo-
grafts, cryopreserved aortic allografts prepared without antibiotics; AB-treated allografts, cryopreserved aortic allografts prepared with
antibiotics; NS, not significant.
p values are for allografts versus initial grafts.
Fig. 4. Perianastomotic tissues of a dog 21 days after implantation of an antibiotic-treated
allograft. Hematoxylin-eosin stain at original magnification of · 80 demonstrates noninflam-
matory adventitial and perianastomotic fibrosis (*) adjacent to the media (M).
anastomotic sites and all of the prosthetic replace-
ment grafts of the control group were infected at the
time of death.
The mechanisms by which cryopreserved aortic
allografts resist infection are not well defined. Dif-
ferent factors can be hypothesized. As was shown by
Mitchell and coworkers,27 cryopreservation pre-
serves an amorphous and fibrillar extracellular matrix
that is immunologically inert and protects the graft
from autolysis. Compared with fresh allografts, the
cryopreserved allografts appear to keep their intimal
integrity, which results in a reduced surface throm-
bogenicity28 and reduces the risk of hematogenous
bacterial colonization. The active and passive
immunologic properties of aortic allografts, like the
presence of MHC class I and II molecules29 with
subsequent T-cell activation30 or the expression of
endothelial-leukocyte adhesion molecules such as
endothelial leucocyte adhesion molecule-1, vascular
cellular adhesion molecule-1, and intercellular adhe-
sion molecule-1, which can be induced after cryop-
reservation,31 may play a role in modulating the host
defenses and bacterial adherence. All of these
hypothesizes need to be verified by further experi-
mental studies.
However, in our experience the resistance of
untreated cryopreserved aortic allografts was not
complete. Persistent perigraft infection and reinfec-
tion of the replacement graft, even with other bacte-
ria present at the time of reoperation in a septic
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Table III. Microscopic evaluation of the anastomotic sites of prosthetic grafts and cryopreserved aortic
allografts
Perianastomotic
inflammatory Polymorphonuclear Suppurative Mean
infiltration cells necrosis Aortitis score*
Group I
Initial grafts 10/12 7/12 2/12 1/12 20/48
Control grafts 10/12 8/12 4/12 3/12 25/48 (NS)
Group II
Initial grafts 10/12 7/12 1/12 0/12 18/48
Untreated allografts 8/12 3/12 (NS) 1/12 2/12 (NS) 14/48 (NS)
Group III
Initial grafts 10/12 8/12 3/12 1/12 22/48
AB-treated allografts 8/12 3/12 (p < 0.05) 0/12 (NS) 0/12 (NS) 11/48 (p < 0.01)
*Mean score is perianastomotic inflammatory infiltration + polymorphonuclear cells + suppurative necrosis + aortitis.
Initial grafts, colonized gelatin-sealed knitted polyester grafts implanted for 7 days; control grafts, in situ replacement with gelatin-sealed
knitted polyester grafts; untreated allografts, cryopreserved aortic allografts prepared without antibiotics; AB-treated allografts, cryopre-
served aortic allografts prepared with antibiotics; NS, not significant.
p values are for allografts versus initial grafts.
Table IV. Bacteriologic evaluation of graft infection with S. epidermidis RP-62
No. with positive culture/total examined
Viable counts 
Grafts Fragments (CFU/cm2): median (range)
Group I
Initial grafts 6/6 12/12 7.9 · 104 (6 · 103 to 1 · 106)
Control grafts 6/6 12/12 9.8 · 104 (1.6 · 104 to 1.1 · 106)
Group II
Initial grafts 6/6 12/12 2.03 · 104 (1.94 · 103 to 4.61 · 105)
Untreated allografts 1/6* 2/12† 5.54 · 104
Group III
Initial grafts 6/6 12/12 3.32 · 103 (1.03 · 103 to 2.95 · 104)
AB-treated allografts 0/6* 0/12‡ 0
Initial grafts, colonized gelatin-sealed knitted polyester grafts implanted for 7 days; control grafts, in situ replacement with gelatin-sealed
knitted polyester grafts; untreated allografts, cryopreserved aortic allografts prepared without antibiotics; AB-treated allografts, cryopre-
served aortic allografts prepared with antibiotics.
*p < 0.01 when compared with control grafts and initial grafts.
†p < 0.001 when compared with control grafts and initial grafts.
‡p < 0.0001 when compared with control grafts and initial grafts.
operation field, remain a risk. Antibiotic loading
resulting from the 48-hour decontamination in a
medium supplemented with antibiotics performed
before cryopreservation of the allografts might then
have contributed to the increased resistance to infec-
tion of the aortic allografts that we observed in the
animals of group III. Previous experimental studies
with antibiotic-bonded prosthetic grafts demon-
strated that rifampin-bonded gelatin-sealed poly-
ester grafts were highly resistant to early reinfection
after in situ replacement of an infected graft.23,32 In
the present work, the study strain was highly sensi-
tive to vancomycin, and the concentration of van-
comycin in the decontaminating solution was very
high. The antibiotic may then have been carried over
in the tissues surrounding the allografts after implan-
tation, playing a role in the treatment of graft infec-
tion. The antibiotic-treated allografts were perfectly
incorporated with negative bacterial cultures and
significantly decreased histologic signs of inflamma-
tion when compared with the initial grafts (p < 0.01)
at the time of death, whereas persistent perigraft
infection and reinfection of the replacement allo-
grafts were observed in three of the six untreated
allografts. The group C b -hemolytic streptococci
and the S. chromogenes that grew from two untreat-
ed allografts in group II were probably contaminants
that colonized the allografts at the time of graft
replacement in a septic field. Because these allografts
were not antibiotic-treated, the bacteria could grow,
leading to reinfection. The 3-week duration of
implantation chosen for the replacement grafts in
this study may appear short and does not allow the
exclusion of the occurrence of a late infection. Nev-
ertheless, negative bacterial cultures and the perfect
incorporation of the allografts can be considered as
an evidence of their resistance to early reinfection.
In this study, the antibiotic treatment of the allo-
grafts was performed according to the clinical pro-
tocol used for vascular allografts by the tissue bank,
using vancomycin and lincomycin to decontaminate
the allografts. Nevertheless, the demonstrated role
of antibiotics in the resistance of allografts to infec-
tion should have important implications for the
antibiotic procurement of cryopreserved aortic allo-
grafts. The antibiotics used in the cryopreservation
process should be chosen not only in regard to the
decontamination of the allograft but also in regard
to the spectrum of bacteria involved in the infections
intended to treat by in situ replacement with cryop-
reserved aortic allografts. Further experimental stud-
ies are necessary to determine the optimal antibiotics
for the preparation of aortic allografts.
Although late deterioration may be expected
with arterial allografts stored at 4° C,13 excellent
long-term results have been reported by heart sur-
geons with cryopreserved allograft replacement for
management of infections that involve the ascending
aorta.19,33 Future modifications in the techniques of
allograft preparation and cryopreservation should
allow the reduction of antigenicity and have better
long-term results. In conclusion, cryopreserved aor-
tic allografts are a suitable material for arterial recon-
struction in grossly infected fields. In this animal
model, even without adjunct antibiotic therapy, aor-
tic allografts were capable of bringing a prosthetic
graft infection into complete remission within a 3-
week period of time. However, the antibiotic pro-
curement of cryopreserved aortic allograft appears
to be essential to obtain optimal therapeutic effects.
We are indebted to Thierry Marchix, BS, and Roger
Gouezo, BS, for their technical assistance in cryopreserva-
tion of the allografts; to Virginie Metral, MD, for her
technical assistance in bacteriologic preparations; and to
Mrs. Martine Douheret for her technical assistance in his-
tologic processing. We also thank Sulzer-Vascutek Ltd. for
providing the prosthetic grafts used in this study.
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